Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | CCR4 | P51679 | 4/20 | 0.46 |
| ▸ | DRD2 | P14416 | 3/20 | 0.46 |
| ▸ | DRD4 | P21917 | 3/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.45 |
| ▸ | MC4R | P32245 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6968264 | 1.00 | OPRK1 (0.56) | OPRK1LMNASMN1; SMN2MAPTTSHR | |
| SCHEMBL6974472 | 0.96 | LMNA (0.52) | OPRK1LMNASMN1; SMN2MAPTTSHR | |
| SCHEMBL6971418 | 0.95 | LMNA (0.54) | OPRK1LMNASMN1; SMN2MAPTTSHR | |
| SCHEMBL6975047 | 0.94 | OPRK1 (0.48) | OPRK1LMNASMN1; SMN2MAPTTSHR | |
| SCHEMBL6967773 | 0.92 | CXCR4 (0.47) | OPRK1LMNASMN1; SMN2MAPTTSHR | |
| SCHEMBL6972482 | 0.90 | OPRK1 (0.44) | OPRK1CCR4DRD2DRD4DPP7 | |
| SCHEMBL7084048 | 0.90 | LMNA (0.46) | OPRK1LMNASMN1; SMN2MAPTTSHR | |
| SCHEMBL6974967 | 0.90 | OPRK1 (0.45) | OPRK1LMNASMN1; SMN2MAPTTSHR | |
| SCHEMBL6968732 | 0.89 | LMNA (0.52) | OPRK1LMNASMN1; SMN2MAPTTSHR | |
| SCHEMBL7083455 | 0.88 | LMNA (0.47) | OPRK1LMNASMN1; SMN2MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6562964-B1 | Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders | PFIZER INC | 2003-05-13 | — | — | US | disclosed |
| EP-1100797-B1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES | PFIZER LTD (GB) | 2003-02-26 | — | — | EP | disclosed |
| US-6372736-B1 | ENZYME INHIBITORS | PFIZER INC | 2002-04-16 | — | — | US | disclosed |